Clinical Trial: Treating Spinal Cord Injury With Early Normobaric Hyperoxia

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07465302) titled 'Treating Spinal Cord Injury With Early Normobaric Hyperoxia' on Feb. 27.

Brief Summary: SpiCoH is a phase IIa, single center, open-label, clinical trial of intermittent normobaric hyperoxia in mechanically ventilated patients with traumatic cervical and/or thoracic spinal cord injury.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Traumatic Spinal Cord Injuries

Intervention: OTHER: Normobaric Hyperoxia

Intermittent normobaric hyperoxia (NBH) by increasing FiO2 to 100% for a duration of 4.5h (270 min), twice daily over five consecutive days. Instead of fixed 12-hour intervals between sessions, the two dai...